explore -WSS

explore

author：explore 2025-09-03 03:27:11 - browse：5

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Chimpanzees, like humans and whales, get menopause: Study

WSS

Medtronic CEO on promising devices for diabetes, hypertension

Testing for cancer recurrence creates a new limbo for patients

California wildfire smoke linked to 52,000 early deaths, study says

Maker of FluMist seeks to allow at

How faith leaders like me can help address America's obesity epidemic

Readout Newsletter: New research from Sanofi, Regeneron, etc.

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

At least 13 dead in Texas as scorching temps continue

Cigna wins case to block Amy Bricker's move to CVS

Peter Hotez and the public health issue of online harassment

Meta's Zuckerberg and Chan on track to put $50 billion into science

Malaria cases in Florida and Texas: Here’s what you need to know

The pink breast cancer awareness ribbon needs a redesign

Novavax promises a turnaround & Lilly roils the obesity market

Maker of FluMist seeks to allow at

Psychedelics group wrestles with new pharma identity

CDC recommends rationing of RSV shot due to shortages

Wikipedia

Statins may not be needed by millions of people, study suggests

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Cheap, fast test for Zika and dengue could cost just $1

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

The system is set up to fail children with medical complexity

explore

focus

hotspot

leisure time